Medicare Enrolled

Dr. Michael Wangia, MD

MOHS-Micrographic Surgery Physician · Winter Garden, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
1991 DANIELS RD, Winter Garden, FL 34787
4073953770
In practice since 2009 (16 years)
NPI: 1548495955 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wangia from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wangia? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Wangia

Dr. Michael Wangia is a mohs-micrographic surgery physician in Winter Garden, FL, with 16 years in practice. Based on federal Medicare data, Dr. Wangia performed 14,947 Medicare services across 4,153 unique beneficiaries.

Between the years covered by Open Payments, Dr. Wangia received a total of $14,502 from 45 pharmaceutical and/or device companies across 450 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in mohs-micrographic surgery physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Wangia is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice▲ Top 10% volume in FL$ $14,502 industry payments

Medicare Practice Summary

Medicare Utilization ↗
14,947
Medicare services
Top 10% in FL for mohs-micrographic surgery physician
4,153
Unique beneficiaries
$34
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~934 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Photodynamic therapy gel for precancerous skin6,800$1$3
Destruction of precancerous skin growths, 2-141,615$5$13
Tissue pathology examination, moderate complexity1,399$27$72
Office visit, established patient (20-29 min)676$63$179
Destruction of precancerous skin growth, 1549$32$132
Skin biopsy, tangential533$59$199
Biopsy of related skin growth, each additional growth415$39$100
Destruction of skin growths (warts/lesions), 1-14390$80$222
Steroid injection (triamcinolone)351$1$2
Office visit, established patient (30-39 min)324$91$254
Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks191$481$1,339
Office visit, established patient (10-19 min)185$41$112
Tissue staining for diagnosis, additional137$21$55
New patient office visit (30-44 min)134$77$225
New patient office visit (45-59 min)126$119$333
Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks119$318$811
Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm92$202$939
Tissue staining for diagnosis, initial92$26$68
Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm85$243$844
Drug injection, under skin or into muscle64$9$28
Special stained specimen slides to identify organisms including interpretation and report59$20$52
Destruction of precancer skin growth, 15 or more growths46$127$334
Injection into skin growth, 1-7 growths39$29$113
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm36$120$354
Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks36$445$1,257
Pathology examination of tissue using a microscope, moderately low complexity36$8$22
Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm35$95$484
Application of light with debridement to destroy precancer skin growth33$207$542
Punch biopsy, first skin growth31$94$247
Biopsy of ear28$51$192
Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm27$146$409
Removal of tissue from wound, 20.0 sq cm or less26$71$196
Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm25$126$383
Strapping, unna boot25$36$125
Punch biopsy, each additional skin growth24$46$117
Complicated repair of wound of trunk, 2.6-7.5 cm23$288$789
Application of skin substitute graft to wound of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 25.0 sq cm or less of wound 100.0 sq cm or less22$113$316
Acne surgery20$84$230
Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks20$304$774
Office visit, established patient, complex (40-54 min)18$130$356
Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm17$79$341
Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm17$109$556
Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 1.1-2.5 cm16$152$774
Simple or single drainage of skin abscess11$97$249
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.1% high complexity
9.9% medium
89.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$14,502
Total received (2018-2024)
Avg $2,072/year across 7 years
Top 16% in FL for mohs-micrographic surgery physician
45
Companies
450
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,048 (69.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,988 (27.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$466 (3.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,899
2023
$1,701
2022
$1,319
2021
$1,506
2020
$774
2019
$5,682
2018
$1,621

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GENZYME CORPORATION
$4,261
Regeneron Healthcare Solutions, Inc.
$1,717
Novartis Pharmaceuticals Corporation
$1,281
E.R. Squibb & Sons, L.L.C.
$805
Janssen Biotech, Inc.
$621
Lilly USA, LLC
$582
AbbVie, Inc.
$420
PFIZER INC.
$383
Galderma Laboratories, L.P.
$322
ORGANOGENESIS INC.
$292
Amgen Inc.
$268
ABBVIE INC.
$258
LEO Pharma Inc.
$245
Mayne Pharma Inc.
$243
Genentech USA, Inc.
$240
Sun Pharmaceutical Industries Inc.
$216
AbbVie Inc.
$214
Ortho Dermatologics, a division of Bausch Health US, LLC
$210
Biofrontera Inc.
$174
Organogenesis Inc.
$161
Dermavant Sciences, Inc.
$141
Journey Medical Corporation
$137
VYNE Pharmaceuticals Inc.
$135
Almirall LLC
$131
Allergan Inc.
$108
SUN PHARMACEUTICAL INDUSTRIES INC.
$104
MAYNE PHARMA INC.
$102
Janssen Scientific Affairs, LLC
$101
Smith+Nephew, Inc.
$88
SANOFI-AVENTIS U.S. LLC
$77
Celgene Corporation
$69
DUSA Pharmaceuticals, Inc.
$63
UCB, Inc.
$60
Arcutis Biotherapeutics, Inc.
$42
Sensus Healthcare, Inc.
$42
Incyte Corporation
$34
DERMIRA, INC.
$28
Boehringer Ingelheim Pharmaceuticals, Inc.
$23
Aclaris Therapeutics, Inc.
$21
Merck Sharp & Dohme LLC
$21
Paratek Pharmaceuticals, Inc.
$15
Glenmark Therapeutics Inc.
$13
Novum Pharma, LLC
$13
STRATA Skin Sciences, Inc.
$12
MAYNE PHARMA COMMERCIAL LLC
$11
Top 3 companies account for 50.1% of total payments
Associated products mentioned in payments ›
20% · ADBRY · AKLIEF · ALTRENO · AMELUZ · AMZEEQ · ARAZLO · Alcortin A · BLU-U · BRYHALI · Bimzelx · CIBINQO · COLLAGENASE SANTYL · COSENTYX · Cimzia · DERMATITIS - DISEASE · DISEASE STATE · DORYX · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ENSTILAR · EPIDUO FORTE · EPSOLAY · ESKATA · EUCRISA · Enbrel · Erivedge · HUMIRA · Humira · ILUMYA · Ilumya · KEYTRUDA · LIBTAYO · LITFULO · Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution · Mupirocin Cream · NUZYRA · OASIS · ODOMZO · OLUMIANT · OPZELURA · ORACEA · Otezla · Puraply · Puraply Antimicrobial · REMICADE · RINVOQ · SILIQ · SKYRIZI · SPEVIGO · STELARA · Seysara · Sotyktu · TALTZ · TREMFYA · Tremfya · VTAMA · Winlevi · XTRAC · Xolair · ZILXI · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (69%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $97 per 100 Medicare services performed
Looking for a mohs-micrographic surgery physician in Winter Garden?
Compare mohs-micrographic surgery physicians in the Winter Garden area by procedure volume, costs, and industry payment transparency.
Browse mohs-micrographic surgery physicians nearby

Geographic Context

MOHS-Micrographic Surgery Physicians within 10 mi
7
Per 100K population
0.5
County median income
$77,011
Nearest hospital
ORLANDO HEALTH-HEALTH CENTRAL HOSPITAL
8.1 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Wangia is a mixed practice specialist, with above-average Medicare volume (top 10% in FL), and high industry engagement (low-engagement, top 16%), with 16 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Wangia experienced with photodynamic therapy gel for precancerous skin?
Based on Medicare claims data, Dr. Wangia performed 6,800 photodynamic therapy gel for precancerous skin services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wangia receive payments from pharmaceutical companies?
Yes. Dr. Wangia received a total of $14,502 from 45 companies across 450 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wangia's costs compare to other mohs-micrographic surgery physicians in Winter Garden?
Dr. Wangia's average Medicare payment per service is $34. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wangia) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →